The Cigna Group (NYSE:CI)
$ 279.46 -3.62 (-1.28%) Market Cap: 73.93 Bil Enterprise Value: 97.26 Bil PE Ratio: 11.85 PB Ratio: 1.75 GF Score: 53/100

Q4 2025 Cigna Group Earnings Call Transcript

Feb 05, 2026 / 01:30PM GMT
Release Date Price: $284.53 (+4.72%)

Key Points

Positve
  • The Cigna Group (CI) delivered full year adjusted revenue of $275 billion, representing an 11% growth.
  • Full year adjusted earnings per share increased by 9% to $29.84, showcasing sustained earnings growth.
  • The company expanded its specialty capabilities, notably through an investment in Field Health Solutions and Shields Health Solutions.
  • A global settlement with the Federal Trade Commission is expected to provide $7 billion in out-of-pocket cost relief over the next 10 years.
  • The Cigna Group (CI) maintained a high retention rate of over 97% for its pharmacy benefit services for 2026.
Negative
  • The company recorded after-tax special item charges of $483 million or $1.82 per share in the fourth quarter.
  • Higher medical costs were noted, equating to approximately 60 basis points of MCR or about $50 million.
  • The effective tax rate could increase by up to 1% due to the relocation of the GPO from Switzerland to the US.
  • The individual exchange business is expected to see a decline in membership, with fewer than 300,000 customers by the end of 2026.
  • The company anticipates investment-related costs in 2026 and 2027 to build out technology and infrastructure for the new rebate-free model.
Operator

Ladies and gentlemen, thank you for standing by for the Cigna Group's fourth quarter 2025 results review. (Operator Instructions)

As a reminder, ladies and gentlemen, this conference, including the Q&A session, is being recorded. We'll begin by turning the conference over to Ralph Giacobbe. Please go ahead.

Ralph Giacobbe
Cigna Group - Investor Relations

Thanks. Good morning, everyone. Thanks for joining today's call. I'm Ralph Giacobbe, Senior Vice President of Investor Relations. With me on the line this morning are David Cordani, Cigna Group's Chairman and Chief Executive Officer; Brian Evanko, President and Chief Operating Officer; and Ann Dennison, Chief Financial Officer.

In our remarks today, David, Brian and Ann will cover a number of topics, including our fourth quarter and full year 2025 financial results and our financial outlook for 2026. Following their prepared remarks, David, Brian and Ann will be available for Q&A.

As noted in our earnings release, when describing our financial results, we use certain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot